By Indication

Hereditary Cancer Risk Market Analysis

Cross-industry research covering Hereditary Cancer Risk across 1 market reportspanning Pharmaceuticals & Life Sciences – Molecular Diagnostics / Consumer Genomics.

1 Reports

1 Industries

Reports Covering Hereditary Cancer Risk

Direct to Consumer Genetic Sequencing Market to Reach USD 4.7 Billion by 2033 at 7.2% CAGR

Pharmaceuticals & Life Sciences – Molecular Diagnostics / Consumer Genomics·Market: USD 2.7 Billion (2025)·CAGR: 7.2%

BRCA, Lynch, and PALB2 panels are the highest-margin consumer genomic products and are increasingly co-marketed through oncology networks and OB/GYN practices under a hybrid DTC/clinical model.

22%

Market Share

9.1%

Segment CAGR

Explore More Segments

Browse all market segments across our research coverage.

View all segments